Page last updated: 2024-08-24

brequinar and Acute Disease

brequinar has been researched along with Acute Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dunn, JF; Hart, M; Hatch, J; Li, S; Precht, A	1

Trials

1 trial(s) available for brequinar and Acute Disease

Article	Year
Brequinar sodium significantly reduces the incidence of steroid-resistant rejection and resource utilization in primary renal transplant patients compared with azathioprine. Transplantation proceedings, 1996, Volume: 28, Issue:2 Topics: Acute Disease; Adolescent; Adult; Aged; Antilymphocyte Serum; Azathioprine; Biphenyl Compounds; Drug Resistance; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Length of Stay; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Patient Readmission	1996

Article

Year

Brequinar sodium significantly reduces the incidence of steroid-resistant rejection and resource utilization in primary renal transplant patients compared with azathioprine.

Transplantation proceedings, 1996, Volume: 28, Issue:2

Topics: Acute Disease; Adolescent; Adult; Aged; Antilymphocyte Serum; Azathioprine; Biphenyl Compounds; Drug Resistance; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Length of Stay; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Patient Readmission

1996